Results 211 to 220 of about 290,514 (386)

Bio‐Based Epoxy Resins from Estragole: Achieving High Glass Transition Temperatures Comparable to DGEBA and Simultaneously Low Viscosities

open access: yesMacromolecular Materials and Engineering, EarlyView.
Two novel bio‐based epoxy monomers, diglycidyl‐4‐allylphenol (DG‐4A) and triglycidyl‐diallylphenol (TG‐DA), derived from estragole (92% and 72% bio‐content), were synthesized and cured with isophorone diamin (IPDA) and 4,4´‐diaminodiphenyl sulfone (DDS). The resins show high Tgs, with DG‐4A reaching and TG‐DA exceeding DGEBA‐based systems. These resins
Florian Bauer   +4 more
wiley   +1 more source

Estrogen Replacement Therapy and Prognosis after First Myocardial Infarction [PDF]

open access: bronze, 1997
Katherine M. Newton   +6 more
openalex   +1 more source

Polymerized Pro‐Estrogen Microneedles via Two Photon Polymerization

open access: yesMacromolecular Rapid Communications, EarlyView.
Acrylic pro‐drugs of 17β‐estradiol were subjected to spatially controlled two‐photon polymerization to create bespoke microneedle geometries with potential biomedical applications for long‐term transdermal hormone delivery. ABSTRACT Two‐photon polymerization (TPP) is a powerful technique to create microscale structures with high precision, offering ...
Yang Lou   +6 more
wiley   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Incidence and Mortality Risks of Gastrointestinal Cancers During Working‐Age Period: Trends and Disparities in 204 Countries and Territories (1990–2021)

open access: yesMed Research, EarlyView.
This comprehensive analysis of gastrointestinal (GI) cancer risk reveals that globally, one in 46 people will develop and one in 73 will die from GI cancers during working age (15–64 years), with 2021 incidence and mortality risks of 2.19% and 1.37%, respectively. Key findings demonstrate striking gender disparities, with males facing nearly double the
Yiming Song   +14 more
wiley   +1 more source

MNGI-03. ESTROGEN HORMONE REPLACEMENT THERAPY IN INCIDENTAL MENINGIOMA - A GROWTH RATE ANALYSIS [PDF]

open access: bronze, 2019
David Kamson   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy